{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:30:46Z","timestamp":1789036246753,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,7]],"date-time":"2027-01-07T00:00:00Z","timestamp":1799280000000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25H01049"],"award-info":[{"award-number":["25H01049"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K22091"],"award-info":[{"award-number":["24K22091"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ek0210200"],"award-info":[{"award-number":["JP24ek0210200"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ek0109766"],"award-info":[{"award-number":["JP24ek0109766"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23gm6710012"],"award-info":[{"award-number":["JP23gm6710012"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jjcc.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T06:37:29Z","timestamp":1754721449000},"page":"64-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perivascular adipose tissue in cardiovascular disease: From mechanisms to therapeutic targets"],"prefix":"10.1016","volume":"87","author":[{"given":"Kazutaka","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.08.001_bb0005","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.301312","article-title":"Inflammatory and immune responses in the arterial media","volume":"116","author":"Tellides","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0010","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1161\/01.ATV.0000188508.40052.35","article-title":"Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?","volume":"25","author":"Henrichot","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0015","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/ATVBAHA.118.311367","article-title":"Brown adipocyte-specific PPAR\u03b3 (peroxisome proliferator-activated receptor \u03b3) deletion impairs perivascular adipose tissue development and enhances atherosclerosis in mice","volume":"38","author":"Xiong","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01004","article-title":"Editorial: Perivascular adipose tissue (PVAT) in health and disease","volume":"9","author":"Watts","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0025","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/ATVBAHA.114.303029","article-title":"Perivascular adipose tissue in vascular function and disease: a review of current research and animal models","volume":"34","author":"Brown","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0030","doi-asserted-by":"crossref","first-page":"H1425","DOI":"10.1152\/ajpheart.00376.2011","article-title":"Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation","volume":"301","author":"Fitzgibbons","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000582","article-title":"Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations","volume":"3","author":"Fitzgibbons","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fphys.2017.00969","article-title":"The role of perivascular adipose tissue in non-atherosclerotic vascular disease","volume":"8","author":"Horimatsu","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0045","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/ATVBAHA.114.303033","article-title":"Perivascular adipose tissue and coronary vascular disease","volume":"34","author":"Owen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0050","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cell.2008.09.036","article-title":"Identification of white adipocyte progenitor cells in vivo","volume":"135","author":"Rodeheffer","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0055","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1073\/pnas.0610615104","article-title":"Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages","volume":"104","author":"Timmons","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.devcel.2017.04.012","article-title":"A molecular switch regulating cell fate choice between muscle progenitor cells and brown adipocytes","volume":"41","author":"An","year":"2017","journal-title":"Dev Cell"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature07182","article-title":"PRDM16 controls a brown fat\/skeletal muscle switch","volume":"454","author":"Seale","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0070","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrm.2016.96","article-title":"Control of brown and beige fat development","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tem.2018.01.001","article-title":"The common and distinct features of brown and beige adipocytes","volume":"29","author":"Ikeda","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1194\/jlr.M600287-JLR200","article-title":"Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat","volume":"48","author":"Xue","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0085","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cmet.2014.03.025","article-title":"A smooth muscle-like origin for beige adipocytes","volume":"19","author":"Long","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0090","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/ncomms5099","article-title":"Adipocytes arise from multiple lineages that are heterogeneously and dynamically distributed","volume":"5","author":"Sanchez-Gurmaches","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s42255-021-00380-0","article-title":"Defining the lineage of thermogenic perivascular adipose tissue","volume":"3","author":"Angueira","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0100","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/ATVBAHA.120.314731","article-title":"Pathological conversion of mouse perivascular adipose tissue by notch activation","volume":"40","author":"Boucher","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.112.104489","article-title":"Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-\u03b3 deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis","volume":"126","author":"Chang","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fphys.2018.00070","article-title":"PVAT and its relation to brown, beige, and white adipose tissue in development and function","volume":"9","author":"Hildebrand","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0115","first-page":"277","article-title":"Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness","volume":"13","author":"Soltis","year":"1991","journal-title":"Clin Exp Hypertens A"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0120","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between adipocyte size and adipokine expression and secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0125","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators","volume":"108","author":"Mazurek","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1089\/ars.2020.8103","article-title":"Roles of perivascular adipose tissue in hypertension and atherosclerosis","volume":"34","author":"Hu","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10557-018-6821-y","article-title":"Remote effects of transplanted perivascular adipose tissue on endothelial function and atherosclerosis","volume":"32","author":"Horimatsu","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.01032","article-title":"Mitoneet in perivascular adipose tissue blunts atherosclerosis under mild cold condition in mice","volume":"8","author":"Xiong","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020637","article-title":"Perivascular adipose tissue is a major source of nitric oxide in saphenous vein grafts harvested via the no-touch technique","volume":"11","author":"Saito","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12933-018-0777-x","article-title":"Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword","volume":"17","author":"Qi","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0155","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, adipose tissue and vascular dysfunction","volume":"128","author":"Koenen","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000885","article-title":"Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study","volume":"1","author":"Thanassoulis","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0165","article-title":"Characterization of stromal vascular fraction and adipose stem cells from subcutaneous, preperitoneal and visceral morbidly obese human adipose tissue depots","volume":"12","author":"Silva","year":"2017","journal-title":"PloS One"},{"issue":"58","key":"10.1016\/j.jjcc.2025.08.001_bb0170","article-title":"Na\u00efve, regulatory, activated, and memory immune cells co-exist in PVATs that are comparable in density to non-PVAT fats in health","volume":"11","author":"Kumar","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32658-6","article-title":"Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling","volume":"13","author":"Adachi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0185","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jjcc.2022.08.010","article-title":"Role of DNA damage in the pathogenesis of atherosclerosis","volume":"81","author":"Ishida","year":"2023","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0195","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.42","article-title":"ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation","volume":"8","author":"Schumacher","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7356","article-title":"Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development","volume":"6","author":"Berb\u00e9e","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0210","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1073\/pnas.1901655116","article-title":"Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis","volume":"116","author":"Sui","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cmet.2013.06.003","article-title":"Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis","volume":"18","author":"Dong","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0225","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jjcc.2025.08.001_bb0235","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","article-title":"Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy","volume":"18","author":"Dutour","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.jjcc.2025.08.001_bb0240","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.jjcc.2025.08.001_bb0245","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00592-014-0710-z","article-title":"Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study","volume":"52","author":"Morano","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0250","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/db14-0302","article-title":"GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK","volume":"63","author":"Beiroa","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2019.04.039","article-title":"Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk?","volume":"292","author":"Dozio","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0260","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0270","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","article-title":"Tirzepatide reduces LV mass and paracardiac adipose tissue in obesity-related heart failure: SUMMIT CMR substudy","volume":"85","author":"Kramer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0275","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0280","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0285","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study","volume":"9","author":"Requena-Ib\u00e1\u00f1ez","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0290","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/oby.22798","article-title":"Effects of dapagliflozin on epicardial fat thickness in patients with type 2 diabetes and obesity","volume":"28","author":"Iacobellis","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0295","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","article-title":"The effect of dapagliflozin treatment on epicardial adipose tissue volume","volume":"17","author":"Sato","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-017-0275-4","article-title":"Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus","volume":"9","author":"Yagi","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0305","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s13300-017-0279-y","article-title":"Ipragliflozin reduces epicardial fat accumulation in non-obese type 2 diabetic patients with visceral obesity: a pilot study","volume":"8","author":"Fukuda","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jjcc.2025.08.001_bb0310","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12933-019-0947-5","article-title":"Luseogliflozin attenuates neointimal hyperplasia after wire injury in high-fat diet-fed mice via inhibition of perivascular adipose tissue remodeling","volume":"18","author":"Mori","year":"2019","journal-title":"Cardiovasc Diabetol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:40:34Z","timestamp":1772811634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508725002059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0914508725002059"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.08.001","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perivascular adipose tissue in cardiovascular disease: From mechanisms to therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}